中文产业新闻精选评分77Chinese source
百济神州替雷利珠单抗联合泽尼达妥单抗及化疗获FDA批准，用于HER2阳性胃食管腺癌一线治疗
百济神州双药联合获FDA批准，HER2阳性胃食管腺癌患者无论PD-L1表达均获益
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.
百济神州双药联合获FDA批准，HER2阳性胃食管腺癌患者无论PD-L1表达均获益
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.